Nonalcoholic Fatty Liver Disease in Women and Girls With Polycystic Ovary Syndrome

Hepatic steatosis relates to gastrointestinal microbiota changes in obese girls with polycystic ovary syndrome

(2021) Beza Jobira et al.   PLoS One

The effects of canola and olive oils consumption compared to sunflower oil, on lipid profile and hepatic steatosis in women with polycystic ovarian syndrome: a randomized controlled trial

(2021) Maryam Yahay et al.   Lipids in Health and Disease

Effects of chronic HBV infection on lipid metabolism in non-alcoholic fatty liver disease: A lipidomic analysis

(2021) Han Li et al.   Annals of Hepatology

Polycystic ovary syndrome with feasible equivalence to overweight as a risk factor for non-alcoholic fatty liver disease development and severity in Mexican population

(2020) Nicolás Salva-Pastor et al.   Annals of Hepatology

Lipid accumulation product independently correlate with hepatic steatosis quantified by controlled attenuation parameter in women with polycystic ovary syndrome

(2020) Silan Zheng et al.   Endocrine Connections

ROLE OF ANDROGEN IN LIVER FAT CONTENT IN WOMEN: METABOLICALLY ADVANTAGEOUS OR DISADVANTAGEOUS?

(2020) Yuying Wang et al.   Endocrine Practice

Endocrine Disruptors, Obesity, and Cytokines - How Relevant Are They to PCOS?

(2020) M. ŠIMKOVÁ et al.   PHYSIOLOGICAL RESEARCH

Dynamic Changes in Circulating Endocrine FGF19 Subfamily and Fetuin-A in Response to Intralipid and Insulin Infusions in Healthy and PCOS Women

(2020) Manjunath Ramanjaneya et al.   Frontiers in Endocrinology

Prevalence and predictors of nonalcoholic fatty liver disease in South Asian women with polycystic ovary syndrome

(2020) Mohamed Shengir et al.   WORLD JOURNAL OF GASTROENTEROLOGY

A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome

(2019) Zeeshan Javed et al.   Nutrients

Clinical prediction score of non‐alcoholic fatty liver disease in adolescent girls with polycystic ovary syndrome ( PCOS ‐ HS index)

(2019) Anne‐Marie Carreau et al.   CLINICAL ENDOCRINOLOGY

Abdominal Obesity as a Predictive Factor of Nonalcoholic Fatty Liver Disease Assessed by Ultrasonography and Transient Elastography in Polycystic Ovary Syndrome and Healthy Women

(2019) Siriluk Tantanavipas et al.   Biomed Research International

Increased serum fetuin-B concentration is associated with HOMA-β and indices of liver steatosis in women with polycystic ovary syndrome: a pilot study

(2019) Agnieszka Adamska et al.   Endocrine Connections

Asporin levels are low in patients with nonalcoholic fatty liver disease and increase after vitamin E treatment

(2019) Stergios A. Polyzos et al.   Hormones-International Journal of Endocrinology and Metabolism

Polycystic ovary syndrome (PCOS) is associated with NASH severity and advanced fibrosis

(2019) Monika Sarkar et al.   LIVER INTERNATIONAL

Triglycerides as a Metabolic Target in Afrocaribbean Infertile Women with Polycystic Ovary Syndrome

(2019) Charlotte Brouzeng et al.   Metabolic Syndrome and Related Disorders

Ethnicity and Metabolic Syndrome: Implications for Assessment, Management and Prevention

(2019) Scott A. Lear et al.   Nutrients

Statistical primer: sample size and power calculations—why, when and how?†

(2018) Graeme L Hickey et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database

(2018) Balachandran Kumarendran et al.   PLOS MEDICINE

A potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: an update meta-analysis

(2018) Jia Wu et al.   Reproductive Health

Reproductive Endocrinology of Non-Alcoholic Fatty Liver Disease

(2018) Mathis Grossmann et al.   ENDOCRINE REVIEWS

High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance

(2017) J Cai et al.   INTERNATIONAL JOURNAL OF OBESITY

Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS

(2017) Salvatore Petta et al.   PLoS One

Endocannabinoid receptor blockade reduces alanine aminotransferase in polycystic ovary syndrome independent of weight loss

(2017) Alison J. Dawson et al.   BMC Endocrine Disorders

Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments

(2017) Hironori Kitade et al.   Nutrients

Metabolomic profiling identifies potential pathways involved in the interaction of iron homeostasis with glucose metabolism

(2017) Lars Stechemesser et al.   Molecular Metabolism

Anthropologists' views on race, ancestry, and genetics

(2016) Jennifer K. Wagner et al.   AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY

Low Dose Dihydrotestosterone Drives Metabolic Dysfunction via Cytosolic and Nuclear Hepatic Androgen Receptor Mechanisms

(2016) Stanley Andrisse et al.   ENDOCRINOLOGY

Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome

(2016) D. Macut et al.   HUMAN REPRODUCTION

Adverse metabolic phenotype of adolescent girls with non-alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys

(2016) Oyekoya T Ayonrinde et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Hepatic Steatosis is Common in Adolescents with Obesity and PCOS and Relates toDe NovoLipogenesis but not Insulin Resistance

(2016) Melanie Cree-Green et al.   Obesity

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 1

(2015) Neil F. Goodman et al.   Endocrine Practice

Niealkoholowe stłuszczenie wątroby u kobiet z zespołem wielotorbielowatych jajników — aspekty kliniczne i metaboliczne oraz polimorfizm genu lipazy lipoproteinowej

(2015) Anna Bohdanowicz-Pawlak et al.   Endokrynologia Polska

Increased prevalence of polycystic ovary syndrome in premenopausal women with nonalcoholic fatty liver disease

(2015) E Vassilatou et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Association of single-nucleotide polymorphisms rs2197076 and rs2241883 of FABP1 gene with polycystic ovary syndrome

(2015) Hongxi Xue et al.   JOURNAL OF ASSISTED REPRODUCTION AND GENETICS

Liver Injury Indicating Fatty Liver but Not Serologic NASH Marker Improves under Metformin Treatment in Polycystic Ovary Syndrome

(2015) Susanne Tan et al.   International Journal of Endocrinology

In overweight/obese but not in normal-weight women, polycystic ovary syndrome is associated with elevated liver enzymes compared to controls

(2014) Frangiskos Economou et al.   Hormones-International Journal of Endocrinology and Metabolism

M30 Does Not Predict the Severity of Hepatosteatosis, Whereas Adiponectin Level Declined With Increase of ALT and the Severity of Hepatic Steatosis

(2014) Sedat Caner et al.   JOURNAL OF CLINICAL LABORATORY ANALYSIS

Abnormal serum alanine aminotransferase levels are associated with impaired insulin sensitivity in young women with polycystic ovary syndrome

(2014) G. Targher et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome

(2014) Carly E Kelley   WORLD JOURNAL OF GASTROENTEROLOGY

Cannabinoid Receptor 1 Gene Polymorphisms and Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome and in Healthy Controls

(2014) Justyna Kuliczkowska Plaksej et al.   International Journal of Endocrinology

Glucagon-like peptide-1 analogue, liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and nonalcoholic fatty liver disease

(2013) H. Kahal et al.   CLINICAL ENDOCRINOLOGY

Endothelial dysfunction in hyperandrogenic polycystic ovary syndrome is not explained by either obesity or ectopic fat deposition

(2013) Victoria S. Sprung et al.   CLINICAL SCIENCE

Polycystic ovary syndrome and nonalcoholic fatty liver in obese adolescents: association with metabolic risk profile

(2013) Sara F. Michaliszyn et al.   FERTILITY AND STERILITY

Global Adiposity and Thickness of Intraperitoneal and Mesenteric Adipose Tissue Depots Are Increased in Women With Polycystic Ovary Syndrome (PCOS)

(2013) Susana Borruel et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Molecular signature of adipose tissue in patients with both Non-Alcoholic Fatty Liver Disease (NAFLD) and Polycystic Ovarian Syndrome (PCOS)

(2013) Ancha Baranova et al.   Journal of Translational Medicine

Are Africans, Europeans, and Asians Different “Races”? A Guided-Inquiry Lab for Introducing Undergraduate Students to Genetic Diversity and Preparing Them to Study Natural Selection

(2012) Steven T. Kalinowski et al.   CBE-Life Sciences Education

Bisphenol A in polycystic ovary syndrome and its association with liver-spleen axis

(2012) Giovanni Tarantino et al.   CLINICAL ENDOCRINOLOGY

Polycystic Ovary Syndrome with Hyperandrogenism Is Characterized by an Increased Risk of Hepatic Steatosis Compared to Nonhyperandrogenic PCOS Phenotypes and Healthy Controls, Independent of Obesity and Insulin Resistance

(2012) Helen Jones et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

(2011) G. Vernon et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome

(2011) Maria F. Gangale et al.   CLINICAL ENDOCRINOLOGY

Fatty liver index in polycystic ovary syndrome

(2011) Elisabeth Lerchbaum et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Racial influence on the polycystic ovary syndrome phenotype: a black and white case-control study

(2011) Gwinnett Ladson et al.   FERTILITY AND STERILITY

Metformin and/or Clomiphene Do Not Adversely Affect Liver or Renal Function in Women with Polycystic Ovary Syndrome

(2011) Mira Aubuchon et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome

(2011) L. F. N. Zueff et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Hyperandrogenemia Is Independently Associated with Elevated Alanine Aminotransferase Activity in Young Women with Polycystic Ovary Syndrome

(2010) Mei-Jou Chen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Sonographic Measurement of Mesenteric Fat Predicts Presence of Fatty Liver among Subjects with Polycystic Ovary Syndrome

(2010) R. C. W. Ma et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Different differences: The use of ‘genetic ancestry’ versus race in biomedical human genetic research

(2010) Joan H. Fujimura et al.   SOCIAL STUDIES OF SCIENCE

Apoptosis and Cytokines in Non-Alcoholic Steatohepatitis

(2009) Wing-Kin Syn et al.   Clinics in Liver Disease

Hepatic steatosis in young lean insulin resistant women with polycystic ovary syndrome

(2009) Athina Markou et al.   FERTILITY AND STERILITY

The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria

(2009) W. A. March et al.   HUMAN REPRODUCTION

Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome

(2009) E. Vassilatou et al.   HUMAN REPRODUCTION

Omega-3 Fatty Acid Supplementation Decreases Liver Fat Content in Polycystic Ovary Syndrome: A Randomized Controlled Trial Employing Proton Magnetic Resonance Spectroscopy

(2009) Andrea J. Cussons et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Apoptotic Markers Indicate Nonalcoholic Steatohepatitis in Polycystic Ovary Syndrome

(2009) Susanne Tan et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome

(2009) Malgorzata M Brzozowska et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

The Prevalence of Abnormal Liver Enzymes and Metabolic Syndrome in Obese Adolescent Females with Polycystic Ovary Syndrome

(2009) Elaine Barfield et al.   Journal of Pediatric and Adolescent Gynecology

Minorities in academic medicine: Review of the literature

(2009) Marc A. Nivet   JOURNAL OF VASCULAR SURGERY

The effects of 8 months of metformin on circulating GGT and ALT levels in obese women with polycystic ovarian syndrome

(2008) D. Preiss et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE